Back to Search
Start Over
Brain iron deposition is linked with cognitive severity in Parkinson's disease.
- Source :
-
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2020 Apr; Vol. 91 (4), pp. 418-425. Date of Electronic Publication: 2020 Feb 20. - Publication Year :
- 2020
-
Abstract
- Background: Dementia is common in Parkinson's disease (PD) but measures that track cognitive change in PD are lacking. Brain tissue iron accumulates with age and co-localises with pathological proteins linked to PD dementia such as amyloid. We used quantitative susceptibility mapping (QSM) to detect changes related to cognitive change in PD.<br />Methods: We assessed 100 patients with early-stage to mid-stage PD, and 37 age-matched controls using the Montreal Cognitive Assessment (MoCA), a validated clinical algorithm for risk of cognitive decline in PD, measures of visuoperceptual function and the Movement Disorders Society Unified Parkinson's Disease Rating Scale part 3 (UPDRS-III). We investigated the association between these measures and QSM, an MRI technique sensitive to brain tissue iron content.<br />Results: We found QSM increases (consistent with higher brain tissue iron content) in PD compared with controls in prefrontal cortex and putamen (p<0.05 corrected for multiple comparisons). Whole brain regression analyses within the PD group identified QSM increases covarying: (1) with lower MoCA scores in the hippocampus and thalamus, (2) with poorer visual function and with higher dementia risk scores in parietal, frontal and medial occipital cortices, (3) with higher UPDRS-III scores in the putamen (all p<0.05 corrected for multiple comparisons). In contrast, atrophy, measured using voxel-based morphometry, showed no differences between groups, or in association with clinical measures.<br />Conclusions: Brain tissue iron, measured using QSM, can track cognitive involvement in PD. This may be useful to detect signs of early cognitive change to stratify groups for clinical trials and monitor disease progression.<br />Competing Interests: Competing interests: RSW has received personal fees from GE healthcare. A-ES has received personal fees from MedTronic. JA-C has equity and a full-time appointment at Tenoke Limited.<br /> (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.)
- Subjects :
- Aged
Brain metabolism
Brain pathology
Cognition Disorders metabolism
Cognition Disorders pathology
Disease Progression
Female
Humans
Magnetic Resonance Imaging
Male
Mental Status and Dementia Tests
Middle Aged
Parkinson Disease metabolism
Parkinson Disease pathology
Severity of Illness Index
Brain diagnostic imaging
Cognition Disorders diagnostic imaging
Iron metabolism
Parkinson Disease diagnostic imaging
Subjects
Details
- Language :
- English
- ISSN :
- 1468-330X
- Volume :
- 91
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of neurology, neurosurgery, and psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 32079673
- Full Text :
- https://doi.org/10.1136/jnnp-2019-322042